Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Pasithea Therapeutics Corp/

Recent news which mentions Pasithea Therapeutics Corp/

A New BioTech Research Race Is Focused On Improving Life For MS Patients
Tickers AZN JNJ MRNA
Tags XNAS:KTTA Pasithea Therapeutics Corp/
From TheNewswire.com - RSS (Media)
A New BioTech Research Race Is Focused On Improving Life For MS Patients
Tickers AZN BNTX JNJ KTTA
Tags Partner Content Small Cap General
From Benzinga
New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope
Tickers CLNN KTTA MRK
Tags XNAS:KTTA Pasithea Therapeutics Corp/
From TheNewswire.com - RSS (Media)
New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope
Tickers CLNN KTTA MRK
Tags Partner Content General Benzinga
From Benzinga
Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis
Tickers AZN JNJ KTTA MRNA
Tags XNAS:KTTA Pasithea Therapeutics Corp/
From TheNewswire.com - RSS (Media)
Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis
Tickers AZN JNJ KTTA MRNA
Tags Benzinga Biotech Pasithea Therapeutics Corp/
From Benzinga
Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
Tickers AZN EVO KTTA MRK
Tags Benzinga Pasithea Therapeutics Corp/ Biotech
From Benzinga
A Monoclonal Antibody Treatment For ALS Could Begin Human Trials By 2023, According To Pasithea
Tickers BIIB KTTA SNY
Tags SNY Benzinga Penny Stocks
From Benzinga
Pasithea Therapeutics Receives AUD $1 Million Research Award Following Recent Acquisition
Tickers KTTA
Tags Benzinga Penny Stocks Pasithea Therapeutics Corp/
From Benzinga
Pasithea Therapeutics Awarded A Drug Development Research Grant
Tickers KTTA
Tags Partner Content Market News General
From Benzinga
Pasithea Reveals Cash Position Of $52.9 Million In Latest Earnings Report, To Expand Pipeline And Fund Operations Well Into 2024
Tickers KTTA
Tags Biotech Pasithea Therapeutics Corp/ KTTA
From Benzinga
Pasithea Partners With Glimpse Group To Co-Develop VR Environments For Patients With Psychiatric Disorders
Tickers KTTA VRAR
Tags KTTA Biotech Pasithea Therapeutics Corp/
From Benzinga
Pasithea Therapeutics Announces Plans To Open Three New Clinics In The UK By Mid-2022
Tickers KTTA
Tags General Partner Content Market News
From Benzinga
From Mobile Clinics to Drug Development, This Company Is Attempting to Tackle Brain Disorders and Promote Mental Health Advances
Tickers ABVC ANIP EVO KTTA
Tags Partner Content EVO Small Cap
From Benzinga
EXCLUSIVE: Pasithea Clinics Launches In-Home Intravenous Ketamine Therapy In Major US Cities
Tickers KTTA
Tags General Topics Adam Nadelson
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.